Stocks · Healthcare · Biotechnology
ProKidney Corp. PROK
$1.72 +0.58% Close, Oct 2, 2026 · NASDAQ · Market cap $578.4M
Expensive vs sectorHigh risk
Next earnings report: Nov 9, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Operating margin widened to -21664.5% from -34467.0% a year earlier.
- The diluted share count rose 42.7% in a year.
- Revenue over the last four quarters was $818,000, up 55.2% from a year earlier, slowing from 190.5% a quarter earlier.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Top 15%
- Revenue growth accelerationBottom 3%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalBottom 17%
- Gross marginBottom 5%
- Operating marginBottom 3%
- Accruals (lower is better)Bottom 4%
- Interest coverBottom 1%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldBottom 21%
- Free-cash-flow yieldBottom 19%
- EBITDA / enterprise valueBottom 21%
- Sales / enterprise valueBottom 4%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthBottom 19%
- 6-month returnBottom 32%
- 1-year return vs S&P 500Bottom 20%
- Distance from 52-week highBottom 27%
- Trend checklist (0–4)Bottom 38%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersBottom 40%
- Consecutive EPS beatsBottom 20%
- Share of analysts rating BuyBottom 47%
- Upside to consensus price targetTop 23%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Bottom 30%
- Maximum drawdown, 3 yearsBottom 17%
- Beta vs S&P 500 (lower is better)Bottom 8%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 190.5% | 55.2% | ↓ |
| Gross margin | 100.0% | -252.6% | ↓ |
| Operating margin | -34467.0% | -21664.5% | ↑ |
| FCF margin | -27814.0% | -19527.4% | ↑ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 55.2% | 190.5% | ↓ | Top 15% |
| Gross margin | -252.6% | 100.0% | ↓ | Bottom 5% |
| Operating margin | -21664.5% | -34467.0% | ↑ | Bottom 3% |
| Net margin | -10599.8% | -13752.2% | ↑ | — |
| Free-cash-flow margin | -19527.4% | -27814.0% | ↑ | — |
| Return on invested capital | -68.1% | — | Bottom 17% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- 21.9%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 1985.6%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- -101.4 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- Net cash
- Interest cover (operating income / interest)How many times operating profit covers interest.
- -9327.2×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- -3.18%
- Shareholder yield
- -3.18%
- Share count change, 1 year
- +42.7%
- Share count change, 3-year CAGR
- +42.4%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 10, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 0
- Beats in the last 8 reports
- 3 of 8
- Average EPS surprise, last 4
- -0.6%
- Average 2-day reaction, last 8
- -0.6%
- Positive 20 days after report
- 2 of 8
Analysts
- Consensus price target
- $4.67
- Target vs current price
- +171.5%
- Analysts with a rating
- 8
- Share rating Buy or Strong Buy
- 75%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 10, 2026 | -7.1% | +3.0% | -18.9% | +22.6% | — |
| May 15, 2026 | -7.7% | -2.9% | +2.3% | -4.1% | -5.8% |
| Mar 18, 2026 | +12.5% | -2.3% | -16.0% | -5.6% | -22.1% |
| Nov 10, 2025 | +0.0% | -6.6% | -16.6% | -18.7% | -40.1% |
| Aug 12, 2025 | +7.1% | -0.9% | +12.4% | -2.2% | +23.9% |
| May 12, 2025 | +18.8% | +4.0% | +11.8% | +35.8% | +299.2% |
| Mar 17, 2025 | -21.4% | +5.7% | -2.4% | -25.7% | +1.7% |
| Nov 12, 2024 | +0.0% | -4.7% | -22.8% | -5.1% | -26.0% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 10, 2026 | -$0.15 | -$0.14 | -7.1% | $150,000 |
| May 15, 2026 | -$0.14 | -$0.13 | -7.7% | $226,000 |
| Mar 18, 2026 | -$0.14 | -$0.16 | +12.5% | $223,000 |
| Nov 10, 2025 | -$0.12 | -$0.12 | +0.0% | $217,000 |
| Aug 12, 2025 | -$0.13 | -$0.14 | +7.1% | $221,000 |
| May 12, 2025 | -$0.13 | -$0.16 | +18.8% | $230,000 |
| Mar 17, 2025 | -$0.17 | -$0.14 | -21.4% | $76,000 |
| Nov 12, 2024 | -$0.14 | -$0.14 | +0.0% | — |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| EV / Sales | 619.82× | — | — | Bottom 4% |
| Free-cash-flow yield | -27.62% | — | — | Bottom 19% |
| Earnings yield | -33.14% | — | — | Bottom 21% |
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✓ Price above 50-day average
- ✗ Price above 200-day average
- ✗ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 2
- Days above the 200-day average
- 0
- 50-day average slope (20 days)
- +0.7%
- 200-day average slope (20 days)
- -2.4%
- Distance from 50-day average
- +2.4%
- Distance from 200-day average
- -9.6%
- RSI (14)
- 49.6
- Relative volume
- 0.61×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 68.4%
- Volatility vs own 5-year history
- 23th percentile · Normal for this stock
- Beta vs S&P 500 (2 years, weekly)
- 2.25
- Correlation with S&P 500
- 0.08
- Current drawdown from 1-year high
- -47.9%
- Maximum drawdown, 3 years
- -89.3%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Mar 13, 2023 | Apr 8, 2025 | -96.3% | 520 days | Not yet recovered |
| Nov 11, 2022 | Dec 28, 2022 | -51.9% | 31 days | 27 days (Feb 7, 2023) |
| Jul 26, 2022 | Aug 19, 2022 | -41.3% | 18 days | 59 days (Nov 11, 2022) |
| Jun 30, 2021 | Jul 15, 2022 | -30.6% | 262 days | 7 days (Jul 26, 2022) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $578.4M
- EPS, diluted (TTM)
- -$0.57
- Revenue (TTM)
- $818,000
- 52-week range
- $1.30 – $3.48
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $76,000 | $893,000 |
| Gross profit | $0 | $0 | $0 | $76,000 | $893,000 |
| Operating income | -$55.1M | -$153.0M | -$151.5M | -$183.7M | -$165.0M |
| Net income | -$55.1M | -$108.0M | -$35.5M | -$61.2M | -$69.0M |
| EPS (diluted) | -$1.73 | -$1.76 | -$0.57 | -$0.62 | -$0.52 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $76,000 | $230,000 | $221,000 | $217,000 | $225,000 | $226,000 | $150,000 |
| Net income | -$17.9M | -$21.3M | -$16.7M | -$16.6M | -$16.5M | -$19.2M | -$22.6M | -$28.4M |
| EPS (diluted) | -$0.14 | -$0.17 | -$0.13 | -$0.13 | -$0.12 | -$0.14 | -$0.16 | -$0.15 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | -$50.3M | -$77.1M | -$90.1M | -$126.4M | -$120.1M |
| Capital expenditure | -$5.2M | -$1.8M | -$34.2M | -$29.5M | -$15.2M |
| Free cash flow | -$55.5M | -$78.9M | -$124.3M | -$155.9M | -$135.3M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | $71.5M | $6.0M | -$9.5M | $144.3M | $25.6M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $181.6M
- Total assets
- $249.0M
- Total liabilities
- $26.2M
- Total debt
- $3.5M
- Net debt
- -$71.3M
- Shareholders’ equity
- -$883.5M
As of Jun 30, 2026 (filed Aug 10, 2026).
Short interest
- Shares sold short
- 21,445,366
- Days to cover
- 19.04
- Change vs previous report
- +3.4%
FINRA short interest, settlement date Sep 15, 2026.